Thirty-three consecutive liver-transplant recipients were prospectively studied over a 37-mo
period for evidence of cytomegalovirus infection. Sixteen (48%) episodes of cytomegalovirus …

Risk factors for cytomegalovirus and severe bacterial infections were studied prospectively
by univariate, multivariate and time-dependent Cox model analysis in 79 consecutive liver …

Cytomegalovirus (CMV) has been shown to be an important pathogen in liver transplant
recipients. The presence of primary infection and the use of OKT3 monoclonal antibodies …

Cytomegalovirus (CMV) remains a major cause of problems following solid organ
transplantation, accounting for a significant increase in morbidity and affiliated costs …

• During a 43-month period, we performed 248 liver transplantations in 211 patients (127
adults and 84 children). Cytomegalovirus (CMV) disease was documented in 73 recipients …

Cytomegalovirus (CMV) remains the single most important microbial pathogen affecting the
liver transplant patient. As a herpes group virus, it possesses ideal properties for causing …

BACKGROUND: Cytomegalovirus (CMV) infection and related disease is a feared
complication after liver transplantation. Antiviral prophylaxis is recommended in clinical …

It has been reported that cytomegalovirus (CMV) infections increase the susceptibility of
transplant patients for other opportunistic infections. Most of these studies date back from a …

A vast majority of the transplant recipients are cytomegalovirus (CMV)‐seropositive (R+). We
sought to assess variables predictive of CMV infection, specifically in R+ liver transplant …

• From 1986 to 1989, 26 consecutive pediatric liver transplant recipients were followed up at
The Hospital for Sick Children, Toronto, Canada. The patients were reviewed to assess the …